"In this new work, we show that MRI can also detect and evaluate chronic smoldering inflammation which involves microglial cells -- the so-called 'police force' of the brain." -- Daniel Reich, MD, PhD, of the NIH National Institute of Neurological Disorders and Stroke (NINDS) in Bethesda, Maryland, on an imaging-based study on multiple sclerosis.
"This is really not a choice at all." -- Mark Del Monte, JD, CEO and interim executive vice president for the American Academy of Pediatrics, reacting to the Trump administration's new "public charge" rule.
"That there was even a tiny chance I may have changed the trajectory of my life and my family's life in one second due to a stupid mistake -- while in pursuit of my own career aspirations -- was overwhelming." -- Sapna Kudchadkar, MD, PhD, of Johns Hopkins Medicine in Baltimore, on the event that made her consider quitting medicine for good.
"We've got to make them work in a way that doesn't interfere in the practice of medicine." -- Centers for Medicare and Medicaid Services Director Seema Verma, speaking about proposals to modify prior authorization processes.
"Diabetes technology is changing at a very rapid pace." -- James Chamberlain, MD, of St. Mark's Hospital and St. Mark's Diabetes Center in Salt Lake City, on the shift towards automated disease management.
"The least they deserve is a safe place to do their jobs." -- Emergency physician and blogger Edwin Leap, MD, discussing the need to ensure a safe work environment for emergency department personnel.
"While most people assume in this day in age that the harms of cigarette smoking are pretty well understood by the public, this is not true." -- Acting FDA Commissioner Ned Sharpless, MD, announcing the FDA's new proposal for graphic warnings on cigarette packaging.